Literature DB >> 11035740

Salmonella enterica serovar typhimurium-induced maturation of bone marrow-derived dendritic cells.

M Svensson1, C Johansson, M J Wick.   

Abstract

Murine bone marrow-derived dendritic cells (DC) can phagocytose and process Salmonella enterica serovar Typhimurium for peptide presentation on major histocompatibility complex class I (MHC-I) and MHC-II molecules. To investigate if a serovar Typhimurium encounter with DC induces maturation and downregulates their ability to present antigens from subsequently encountered bacteria, DC were pulsed with serovar Typhimurium 24 h prior to coincubating with Escherichia coli expressing the model antigen Crl-OVA. Quantitating presentation of OVA epitopes contained within Crl-OVA showed that Salmonella-pulsed DC had a reduced capacity to process Crl-OVA-expressing E. coli for OVA(257-264)/K(b) and OVA(265-277)/I-A(b) presentation. In addition, time course studies of DC pulsed with Crl-OVA-expressing serovar Typhimurium showed that OVA(257-264)/K(b) complexes could stimulate CD8OVA T-hybridoma cells for <24 h following a bacterial pulse, while OVA(265-277)/I-A(b) complexes could stimulate OT4H T-hybridoma cells for >24 but <48 h. The phoP-phoQ virulence locus of serovar Typhimurium also influenced the ability of DC to process Crl-OVA-expressing serovar Typhimurium for OVA(265-277)/I-A(b) presentation but not for OVA(257-264)/K(b) presentation. Furthermore, pulsing of DC with serovar Typhimurium followed by incubation for 24 or 48 h altered surface expression of MHC-I, MHC-II, CD40, CD54, CD80, and CD86, generating a DC population with a uniform, high expression level of these molecules. Finally, neither the serovar Typhimurium phoP-phoQ locus nor lipopolysaccharides (LPS) containing lipid A modifications purified from phoP mutant strains had a different effect on DC maturation from that of wild-type serovar Typhimurium or purified wild-type LPS. Thus, these data show that Salmonella or Salmonella LPS induces maturation of DC and that this process is not altered by the Salmonella phoP virulence locus. However, phoP did influence OVA(265-277)/I-A(b) presentation by DC infected with Crl-OVA-expressing serovar Typhimurium when quantitated after 2 h of bacterial infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11035740      PMCID: PMC97714          DOI: 10.1128/IAI.68.11.6311-6320.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  57 in total

1.  Salmonella efficiently enter and survive within cultured CD11c+ dendritic cells initiating cytokine expression.

Authors:  I Marriott; T G Hammond; E K Thomas; K L Bost
Journal:  Eur J Immunol       Date:  1999-04       Impact factor: 5.532

2.  Classical MHC class I peptide presentation of a bacterial fusion protein by bone marrow-derived dendritic cells.

Authors:  M Svensson; M J Wick
Journal:  Eur J Immunol       Date:  1999-01       Impact factor: 5.532

3.  Characterization of a monoclonal antibody which detects all murine alpha beta T cell receptors.

Authors:  R T Kubo; W Born; J W Kappler; P Marrack; M Pigeon
Journal:  J Immunol       Date:  1989-04-15       Impact factor: 5.422

4.  Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells.

Authors:  B C Urban; D J Ferguson; A Pain; N Willcox; M Plebanski; J M Austyn; D J Roberts
Journal:  Nature       Date:  1999-07-01       Impact factor: 49.962

5.  Human dendritic cells very efficiently present a heterologous antigen expressed on the surface of recombinant gram-positive bacteria to CD4+ T lymphocytes.

Authors:  S Corinti; D Medaglini; A Cavani; M Rescigno; G Pozzi; P Ricciardi-Castagnoli; G Girolomoni
Journal:  J Immunol       Date:  1999-09-15       Impact factor: 5.422

6.  Trypanosoma cruzi infects human dendritic cells and prevents their maturation: inhibition of cytokines, HLA-DR, and costimulatory molecules.

Authors:  L Van Overtvelt; N Vanderheyde; V Verhasselt; J Ismaili; L De Vos; M Goldman; F Willems; B Vray
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

7.  Coordinate intracellular expression of Salmonella genes induced during infection.

Authors:  D M Heithoff; C P Conner; U Hentschel; F Govantes; P C Hanna; M J Mahan
Journal:  J Bacteriol       Date:  1999-02       Impact factor: 3.490

8.  A Salmonella locus that controls resistance to microbicidal proteins from phagocytic cells.

Authors:  P I Fields; E A Groisman; F Heffron
Journal:  Science       Date:  1989-02-24       Impact factor: 47.728

9.  Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite.

Authors:  J B Hibbs; R R Taintor; Z Vavrin
Journal:  Science       Date:  1987-01-23       Impact factor: 47.728

10.  Interleukin-12 is required for control of the growth of attenuated aromatic-compound-dependent salmonellae in BALB/c mice: role of gamma interferon and macrophage activation.

Authors:  P Mastroeni; J A Harrison; J H Robinson; S Clare; S Khan; D J Maskell; G Dougan; C E Hormaeche
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

View more
  18 in total

Review 1.  Nucleic acid vaccines: tasks and tactics.

Authors:  B S McKenzie; A J Corbett; J L Brady; C M Dyer; R A Strugnell; S J Kent; D R Kramer; J S Boyle; A M Lew
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  Campylobacter jejuni induces maturation and cytokine production in human dendritic cells.

Authors:  Lan Hu; Mechelle D Bray; Manuel Osorio; Dennis J Kopecko
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Activation of murine dendritic cells and macrophages induced by Salmonella enterica serovar Typhimurium.

Authors:  Ruwani Sagarika Kalupahana; Pietro Mastroeni; Duncan Maskell; Barbara Ann Blacklaws
Journal:  Immunology       Date:  2005-08       Impact factor: 7.397

4.  Virulent Salmonella enterica serovar typhimurium evades adaptive immunity by preventing dendritic cells from activating T cells.

Authors:  Jaime A Tobar; Leandro J Carreño; Susan M Bueno; Pablo A González; Jorge E Mora; Sergio A Quezada; Alexis M Kalergis
Journal:  Infect Immun       Date:  2006-11       Impact factor: 3.441

5.  Salmonella enterica Serovar Typhimurium infection of dendritic cells leads to functionally increased expression of the macrophage-derived chemokine.

Authors:  Guo Fu; Odilia L C Wijburg; Paul U Cameron; Jason D Price; Richard A Strugnell
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

6.  In vivo activation of dendritic cells and T cells during Salmonella enterica serovar Typhimurium infection.

Authors:  U Yrlid; M Svensson; A Håkansson; B J Chambers; H G Ljunggren; M J Wick
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

7.  Lipooligosaccharide and polysaccharide capsule: virulence factors of Neisseria meningitidis that determine meningococcal interaction with human dendritic cells.

Authors:  Alexandra Unkmeir; Ulrike Kämmerer; Anne Stade; Claudia Hübner; Sabine Haller; Annette Kolb-Mäurer; Matthias Frosch; Guido Dietrich
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

8.  Salmonella enterica serovar Typhimurium expressing mutant lipid A with decreased endotoxicity causes maturation of murine dendritic cells.

Authors:  Ruwani Kalupahana; A Romina Emilianus; Duncan Maskell; Barbara Blacklaws
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

9.  Differential response of bovine monocyte-derived macrophages and dendritic cells to infection with Salmonella typhimurium in a low-dose model in vitro.

Authors:  Mari Norimatsu; James Harris; Victoria Chance; Gordon Dougan; Christopher J Howard; Bernardo Villarreal-Ramos
Journal:  Immunology       Date:  2003-01       Impact factor: 7.397

10.  Immunogenicity against human papillomavirus type 16 virus-like particles is strongly enhanced by the PhoPc phenotype in Salmonella enterica serovar Typhimurium.

Authors:  David Baud; Jalil Benyacoub; Véronique Revaz; Menno Kok; Françoise Ponci; Martine Bobst; Roy Curtiss; Pierre De Grandi; Denise Nardelli-Haefliger
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.